학술논문
Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion—With an application to the design of a clinical trial in acute myeloid leukemia
Document Type
Article
Author
Source
In: Pharmaceutical Statistics . (Pharmaceutical Statistics, 1 January 2020, 19(1):44-58)
Subject
Language
English
ISSN
15391612
15391604
15391604